The fourth national anti-tuberculosis drug resistance survey in Viet Nam

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 6, 2015, Pages 670-675

  Nhung, N V ^a,b   Hoa, N B ^a,c   Sy, D N ^b   Hennig, C M ^d   Dean, A S ^d  

^a National Tuberculosis Program   (Viet Nam)

^b Vietnam Association for Tuberculosis and Lung Disease   (Viet Nam)

^c INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Drug resistance survey; MDR TB; Tuberculosis; Viet Nam

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; FEMALE; HEALTH SURVEY; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; TREND STUDY; VIET NAM; CHILD; CLUSTER ANALYSIS; DRUG EFFECTS; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; PREDICTIVE VALUE; PRESCHOOL CHILD; PREVALENCE; SPUTUM; TRANSMISSION; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEALTH SURVEYS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; VIETNAM; YOUNG ADULT;

EID: 84929439814     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.14.0785     Document Type: Article

References (16)

1. World Health Organization. Global tuberculosis report, 2013. WHO/HTM/TB/2013.11. Geneva, Switzerland: WHO, 2013.
2. Hoa N B, Sy D N, Nhung N V, Tiermersma E W, Borgdorff M W, Cobelens F G J. National survey of tuberculosis prevalence in Viet Nam. Bull World Health Organ 2010; 88: 273-280.
3. Lönnroth K, Thuong LM, Lambregts K, Quy H T, Diwan V K. Private tuberculosis care provision associated with poor treatment outcome: comparative study of a semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Viet Nam. Int J Tuberc Lung Dis 2003; 7: 165-171.
4. Buu T N, Lönnroth K, Quy H T. Initial defaulting in the National Tuberculosis Programme in Ho Chi Minh City, Viet Nam: a survey of extent, reasons and alternative actions taken following default. Int J Tuberc Lung Dis 2003; 7: 735-741.
5. World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis. 4th ed. WHO/HTM/TB/2009.422. Geneva, Switzerland: WHO, 2009.
6. Skrahina A, Hurevich H, Zalutskaya A, et al. Multidrugresistant tuberculosis in Belarus: the size of the problem and associated risk factors. BullWorld Health Organ 2013; 91: 36-45.
7. Lomtadze N, Aspindzelashvili R, Janjgava M, et al. Prevalence and risk factors for multidrug-resistant tuberculosis in the Republic of Georgia: a population-based study. Int J Tuberc Lung Dis 2009; 13: 68-73.
8. Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med 2012; 366: 2161-2170.
9. Quy H T, Lan N T N, Lönnroth K, Buu T N, Dieu T T N, Hai L T. Public-private mix for improved TB control in Ho Chi Minh City, Viet Nam: an assessment of its impact on case detection. Int J Tuberc Lung Dis 2003; 7: 464-471.
10. Hoa N B, Cobelens F G J, Sy D N, Nhung N V, BorgdorffMW, Tiermsma E W. Diagnosis and treatment of tuberculosis in the private sector, Viet Nam. [Correspondence.] Emerg Infect Dis 2011; 17: 562-564.
11. Lönnroth K, Thuong LM, Linh P D, Diwan V K. Utilization of private and public health-care providers for tuberculosis symptoms in Ho Chi Minh City, Viet Nam. Health Policy Plan 2001; 16: 47-54.
12. Uplekar M, Lönnroth K.MDRandXDR-the price of delaying engagement with all care providers for control of TB and TB/ HIV. [Editorial.] Trop Med Int Health 2007; 12: 473-474.
13. World Health Organization. Global tuberculosis report, 2014. WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
14. Philippine Nationwide Tuberculosis Drug Resistance Survey Team. Nationwide drug resistance survey of tuberculosis in the Philippines. Int J Tuberc Lung Dis 2009; 13: 500-507.
15. Buyankhishig B, Naranbat N, Mitarai S, Rieder H L. Nationwide survey of anti-tuberculosis drug resistance in Mongolia. Int J Tuberc Lung Dis 2011; 15: 1201-1205.
16. Yamada N, Saorith K, Yamakami K, et al. The National Drug Resistance Survey in Cambodia, 2000-2001. Int J Tuberc Lung Dis 2007; 11: 1321-1327.